Shareholders' Equity (Tables)

9 Months Ended

Sep. 30, 2013

Shareholders' Equity

Share-Based Activity

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2013		2012		2013		2012
Share-based compensation expense	$	2,104	$	1,707	$	6,070	$	5,119
Fair value of shares vested		1,242		-		11,743		6,425
Cash received from option exercises		9,561		5,256		23,289		11,928
Tax benefit from option exercises		680		739		1,890		1,268

Schedule Of Changes In Non-Vested Restricted Shares

			Weighted
		Number	Average
		of	Grant
		Shares	Price
Non-vested shares at December 31, 2012		828,686	$	22.50
	Shares granted	291,863		31.66
	Shares vested	(360,337)		21.55
	Shares forfeited	(16,343)		23.11
Non-vested shares at September 30, 2013		743,869	$	26.54

Schedule Of Stock Option Activity

					Weighted
					Average
			Weighted		Remaining
		Number	Average		Contractual
		of	Exercise		Term
		Shares	Price		(in years)
Outstanding at December 31, 2012		1,662,830	$	23.82	2.9
	Options exercised with total intrinsic value of $23,289,000	(960,051)		24.26
Outstanding at September 30, 2013 with aggregate intrinsic value of $11,577,000		702,779	$	23.23	2.8
Vested at September 30, 2013 with aggregate intrinsic value of $11,577,000		702,779	$	23.23	2.8
Exercisable at September 30, 2013 with aggregate intrinsic value of $11,577,000		702,779	$	23.23	2.8

Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share

		Three Months Ended September 30,					Nine Months Ended September 30,
					Per					Per
		Earnings		Shares	Share		Earnings		Shares	Share
		(Numerator)		(Denominator)	Amount		(Numerator)		(Denominator)	Amount
2013:
Net earnings from continuing operations attributable
	to AmSurg Corp. per common share (basic)	$	17,049	31,376	$	0.54	$	53,430	31,267	$	1.71
Effect of dilutive securities options
	and non-vested shares		-	615				-	645
Net earnings from continuing operations attributable
	to AmSurg Corp. per common share (diluted)	$	17,049	31,991	$	0.53	$	53,430	31,912	$	1.67
Net earnings attributable to AmSurg Corp.
	per common share (basic)	$	16,771	31,376	$	0.53	$	53,145	31,267	$	1.70
Effect of dilutive securities options
	and non-vested shares		-	615				-	645
Net earnings attributable to AmSurg Corp.
	per common share (diluted)	$	16,771	31,991	$	0.52	$	53,145	31,912	$	1.67
2012:
Net earnings from continuing operations attributable
	to AmSurg Corp. per common share (basic)	$	15,288	30,819	$	0.50	$	46,907	30,727	$	1.53
Effect of dilutive securities options
	and non-vested shares		-	878				-	831
Net earnings from continuing operations attributable
	to AmSurg Corp. per common share (diluted)	$	15,288	31,697	$	0.48	$	46,907	31,558	$	1.49
Net earnings attributable to AmSurg Corp.
	per common share (basic)	$	15,437	30,819	$	0.50	$	45,749	30,727	$	1.49
Effect of dilutive securities options
	and non-vested shares		-	878				-	831
Net earnings attributable to AmSurg Corp.
	per common share (diluted)	$	15,437	31,697	$	0.49	$	45,749	31,558	$	1.45